Clinical Trial Details


Research Study Summary

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II - ORBIT AF II - Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is designed to evaluate the utilization of target-specific antithrombotic agents, such as factor Xa (FXa) inhibitors and direct thrombin inhibitors, and associated outcomes.


The goal of this US prospective outpatient AF registry is to identify real world treatment patterns in patients with AF(atrial fibrillation), outside of randomized controlled trials. Specifically, the registry will attempt to define current treatment patterns and their relationship with outcomes, including stroke, all-cause mortality, and quality-of-life.

To Learn more

CW ID: 192703
Date Last Changed: January 17, 2014

Clinical Trial Snapshot

Both Male and Female
21 and up
Overall Status
Facility Type



  • Be an adult, 21 years of age or older.
  • Have electrocardiographically confirmed AF.
  • New-onset/first-detected AF diagnosed within the 6 months preceding the baseline visit OR
  • Initiated or transitioned to a FXa inhibitor or a direct thrombin inhibitor within the 3 months preceding the baseline visit.


  • Have atrial flutter only.
  • Have an anticipated life expectancy less than 6 months.
  • . Have transient AF secondary to a reversible condition (eg, hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery).
  • Is participating in a randomized clinical study of any anticoagulation for AF at the time of enrollment.
  • Was enrolled in the ORBIT-AF I registry.


Wendy Schneider, MSN, Clinical Research Coordinator
Holy Cross Jim Moran Heart and Vascular Research Institute
2901 Coral Hills Drive, Suite 240
Coral Springs, FL 33065
Phone: (954) 346-0864
Fax: (954) 753-8067

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.